Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · CFR · Title 21 — Food and Drugs · Part 882 — Neurological Devices · § 882.5802

§ 882.5802. Transcranial magnetic stimulation system for neurological and psychiatric disorders and conditions.

277 words·~1 min read·/us/cfr/t21/s§ 882.5802·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)Identification. A transcranial magnetic stimulation system for neurological and psychiatric disorders and conditions is a prescription, non-implantable device that uses brief duration, rapidly alternating, or pulsed, magnetic fields to induce neural activity in the cerebral cortex. It is not intended for applying or focusing magnetic fields towards brain areas outside cerebral cortex (e.g., cerebellum). A repetitive transcranial magnetic stimulation system that is intended to treat major depressive disorder is classified in § 882.5805. A transcranial magnetic stimulation system for headache is classified in § 882.5808.
(b)Classification. Class II (special controls). The special controls for this device are:
(1)Performance testing must demonstrate electromagnetic compatibility, electrical safety, and thermal safety.
(2)Software verification, validation, and hazard analysis must be performed.
(3)The patient-contacting components of the device must be demonstrated to be biocompatible.
(4)Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested:
(i)Magnetic pulse output testing;
(ii)Magnetic and electrical field testing;
(iii)Testing of the safety features built into the device; and
(iv)Testing of the sound levels patients are exposed to during device use.
(5)The physician and patient labeling must include the following:
(i)The risks and benefits associated with use of the device;
(ii)Detailed instructions to prevent seizures, to monitor the patient for seizure activity during treatment, and to provide seizure management care if one were to occur during treatment; and
(iii)A description of the ear protection to be worn by the patient during use of the device, including the type of protection and its noise reduction rating. [84 FR 9230, Mar. 14, 2019]
Connections1 cite this
Cited by 1 section
Citation graph
cites case law
§ 882.5802
Transcranial magnetic stimulation system for neurological and psychiatric disorders and conditions.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.